Sun, Feb 1, 2015, 7:09 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • starcutspin starcutspin Apr 3, 2012 8:03 PM Flag

    it will be sub .10 until the RS...

    Well no, Brooklyn, a couple cents off the price makes little difference.
    Longs are going to be washed out (weak hands) by the R/S, and insiders will issue themselves new subscription rights so they don't care. That is the price to longs of giving this to the institutional et al, investors by raising the shareprice by a head fake. What will happen then is that the shorts will have a bonanza running this right back down again to where it is today. So, even for a dime, you will end up with a small fraction of the shares you would buy today....for a dime. This is SOP, check it out, that's the way these reverse spits go 90% of the time. Ther is nothing here to suggest otherwise. IMHO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The pumpers won't mention and underestimate the power of the retail longs. They alone will ensure that actc goes sub par on the nasdaq. Also, there's no guarantee that actc makes it to the nasdaq, because it must maintain $4 per share for ninety days before the uplisting.

      So, the R/S, then 90 days of manipulation on the otc, where does that leave the share price?

      News matters not, unless it's a huge JV, one which Rabin says is not possible, and won't happen so early in phase I.

      All other trial news will be positive, and come as a package, which will bost pps for one, two trading sessions at most (like in January), then the dumping begins again.

      OTC - dumping and dilution, Nasdaq = dumping, dilution, AND retail shorting IMO

 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
ImmunoGen, Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST
Medivation, Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST